These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29870803)

  • 1. Expression of long non-coding RNA LINC00973 is consistently increased upon treatment of colon cancer cells with different chemotherapeutic drugs.
    Zinovieva OL; Grineva EN; Prokofjeva MM; Karpov DS; Zheltukhin AO; Krasnov GS; Snezhkina AV; Kudryavtseva AV; Chumakov PM; Mashkova TD; Prassolov VS; Lisitsyn NA
    Biochimie; 2018 Aug; 151():67-72. PubMed ID: 29870803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00973 Induces Proliferation Arrest of Drug-Treated Cancer Cells by Preventing p21 Degradation.
    Karpov DS; Spirin PV; Zheltukhin AO; Tutyaeva VV; Zinovieva OL; Grineva EN; Matrosova VA; Krasnov GS; Snezhkina AV; Kudryavtseva AV; Prassolov VS; Mashkova TD; Lisitsyn NA
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics.
    Di Desidero T; Orlandi P; Fioravanti A; Alì G; Cremolini C; Loupakis F; Gentile D; Banchi M; Cucchiara F; Antoniotti C; Masi G; Fontanini G; Falcone A; Bocci G
    Biochem Pharmacol; 2019 Jun; 164():94-105. PubMed ID: 30953637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with anti-cancer agents results in profound changes in lncRNA expression in colon cancer cells].
    Zinovieva OL; Grineva EN; Prokofjeva MM; Karpov DS; Krasnov GS; Prassolov VS; Mashkova TD; Lisitsyn NA
    Mol Biol (Mosk); 2017; 51(5):841-848. PubMed ID: 29116072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
    Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
    Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
    Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
    Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.
    Li G; Yu K; Li F; Xu K; Li J; He S; Cao S; Tan G
    J Ethnopharmacol; 2014 Apr; 153(2):521-30. PubMed ID: 24631140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
    Allegrini G; Goulette FA; Darnowski JW; Calabresi P
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA LINC00261 sensitizes human colon cancer cells to cisplatin therapy.
    Wang ZK; Yang L; Wu LL; Mao H; Zhou YH; Zhang PF; Dai GH
    Braz J Med Biol Res; 2017 Dec; 51(2):e6793. PubMed ID: 29267503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft.
    Tin MM; Cho CH; Chan K; James AE; Ko JK
    Carcinogenesis; 2007 Jun; 28(6):1347-55. PubMed ID: 17148504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
    Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
    Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
    BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing.
    Sun QL; Zhao CP; Wang TY; Hao XB; Wang XY; Zhang X; Li YC
    Gene; 2015 Nov; 572(1):79-86. PubMed ID: 26164760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.